>
pdufa.bio

Felzartamab

Updated ยทnext FDA decision on the calendar

Felzartamab is a Biogen Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

BIIB catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Biogen Inc. (BIIB). We track 2 catalyst events for this program: 2 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026BIIBReadout · May 2027BIIB

Questions

When is Felzartamab's next FDA decision or readout?

The next tracked catalyst for Felzartamab is a Readout in Dec 2026.

What happened at Felzartamab's most recent FDA decision?

No FDA decision for Felzartamab is in our archive yet.

Who makes Felzartamab?

Biogen Inc. (BIIB).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.